RxDoctor Payments Data

Aland Fernandez, MD

Interventional Cardiology · Safety Harbor, FLNPI 1285623868

Payments from drug & device makers

$442in general payments, 2019–2025

Across 23 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$189
  • Boston Scientific$92
  • Abiomed$33
  • Novartis$24
  • Abbott$21
  • Actelion Pharmaceuticals US, Inc.$20
  • plus $63 from 4 others

What the payments were for

  • Food & beverage$442100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$442 in reported general payments places this provider in the 5th percentile of 623 interventional cardiology providers in Florida.

See all interventional cardiology providers in Florida

Medicare billing

Part B allowed, 2024
$606,499
Medicare patients
1,375
Services billed
6,154

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban741$839,892
XareltoRivaroxaban420$430,365
Repatha SureclickEvolocumab50$53,143
BrilintaTicagrelor43$38,186
Propafenone Hcl579$26,623
ClopidogrelClopidogrel Bisulfate2,346$25,538
MultaqDronedarone Hcl16$24,484
Flecainide Acetate447$22,407
Atorvastatin Calcium1,279$12,466
Metoprolol Succinate1,041$12,119
Amiodarone Hcl427$10,445
Amlodipine Besylate1,774$10,317
Rosuvastatin Calcium599$7,679
LivaloPitavastatin Calcium15$6,707
Ezetimibe217$5,559

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaBrilinta$189$38,18643 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 5th percentile of 623 interventional cardiology providers in Florida.

Other interventional cardiology in Safety Harbor

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →